A carregar...
Lung Cancer in the Era of Precision Medicine
The past decade has been transformative for lung cancer patients, physicians and scientists. The discovery of EGFR mutations that confer sensitivity to tyrosine kinase inhibitors in lung adenocarcinomas in 2004 heralded the beginning of the era of precision medicine for lung cancer. It also precipit...
Na minha lista:
| Publicado no: | Clin Cancer Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4505624/ https://ncbi.nlm.nih.gov/pubmed/25979927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2748 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|